$7.91
0.62[8.50%]
At close: May 31
$7.91
0[0.00%]
After Hours: 7:17PM EDT
Cogent Biosciences
(NASDAQ:COGT)Latest News for Cogent Biosciences Stock (NASDAQ:COGT)
Cogent Biosciences Stock (NASDAQ: COGT)
Categories: All
Friday, May 24, 2024
Thursday, May 23, 2024
Monday, May 13, 2024
Wednesday, May 08, 2024
Tuesday, May 07, 2024
Monday, April 15, 2024
Tuesday, April 09, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
- Citigroup Maintains Buy on Cogent Biosciences, Raises Price Target to $13Benzinga Newsdesk - Feb 26, 2024, 11:45AM
- Cogent Biosciences Q4 EPS $(0.63) Down From $(0.56) YoYHappy Mohamed - Feb 26, 2024, 8:08AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Feb 26, 2024, 8:06AM
- Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price TargetBenzinga Newsdesk - Feb 26, 2024, 4:59AM
Friday, February 23, 2024
Thursday, February 22, 2024
- Cogent Biosciences shares are trading higher after the company announced Part 1b data from its SUMMIT trial evaluating bezuclastinib.Benzinga Newsdesk - Feb 22, 2024, 2:52PM
- Cogent Biosciences Announces Part 1b Data From SUMMIT Trial Evaluating Bezuclastinib In Patients With Nonadvanced Systemic Mastocytosis; 51% Week 12 Mean Change In Total Symptom Score, Including 70% Of Patients Achieving ≥50% Reduction In TSS At Week 12Benzinga Newsdesk - Feb 22, 2024, 2:45PM
Wednesday, February 14, 2024
- Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Feb 14, 2024, 1:18PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Feb 14, 2024, 12:31PM
- Cogent Biosciences shares are trading higher after the company announced an oversubscribed $225 million private placement.Benzinga Newsdesk - Feb 14, 2024, 8:52AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Feb 14, 2024, 8:05AM
- Cogent Biosciences Announced A Private Investment Of Approximately $225M; Pro-forma Cash, Cash Equivalents And Marketable Securities Expected To Fund The Company Into 2027Benzinga Newsdesk - Feb 14, 2024, 7:18AM
Monday, February 12, 2024
Thursday, February 08, 2024
Monday, February 05, 2024
Wednesday, January 10, 2024
Tuesday, January 09, 2024
Friday, December 15, 2023
Monday, December 11, 2023
- Wedbush Downgrades Cogent Biosciences to Neutral, Lowers Price Target to $5Benzinga Newsdesk - Dec 11, 2023, 3:30PM
- Nasdaq Edges Higher; Macy's Shares JumpAvi Kapoor - Dec 11, 2023, 2:26PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Dec 11, 2023, 12:30PM
- Dow Surges 100 Points; Cogent Biosciences Shares PlungeAvi Kapoor - Dec 11, 2023, 12:11PM
- Cogent Biosciences Shares Fall Despite Positive Clinical Trial Updates For Systemic Mastocytosis TreatmentVandana Singh - Dec 11, 2023, 11:37AM
- Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On MondayAvi Kapoor - Dec 11, 2023, 11:07AM
- US Stocks Mixed; Cigna Shares Spike HigherAvi Kapoor - Dec 11, 2023, 10:20AM
- Cogent Biosciences shares are trading lower after the company reported initial data from its ongoing Phase 2 SUMMIT trial and data from Part 1 of its ongoing Phase 2 APEX clinical at ASH 2023.Benzinga Newsdesk - Dec 11, 2023, 9:52AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Dec 11, 2023, 8:06AM
- Cogent Biosciences Reported Data From Part 1 Of Its Ongoing Phase 2 APEX Clinical Trial Evaluating Bezuclastinib In Patients With Advanced Systemic Mastocytosis At The American Society Of HematologyBenzinga Newsdesk - Dec 11, 2023, 7:57AM